EP Patent

EP3761977A1 — Methods of administering intravenous meloxicam in a bolus dose

Assigned to Baudax Bio Inc · Expires 2021-01-13 · 5y expired

What this patent protects

The present disclosure relates to meloxicam bolus formulations and methods of administering the same intravenously, for treatment of pain, which can provide fast onset of pain relief suitable for management of acute moderate to severe pain.

USPTO Abstract

The present disclosure relates to meloxicam bolus formulations and methods of administering the same intravenously, for treatment of pain, which can provide fast onset of pain relief suitable for management of acute moderate to severe pain.

Drugs covered by this patent

Patent Metadata

Patent number
EP3761977A1
Jurisdiction
EP
Classification
—
Expires
2021-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Baudax Bio Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.